Decoy Therapeutics (DCOY) Preferred Dividend Payments (2018)
Decoy Therapeutics (DCOY) posted quarterly Preferred Dividend Payments of $35712.0 for Q4 2018, up 45.29% quarter-over-quarter from $24580.0 in Q3 2018.
Decoy Therapeutics (DCOY) Preferred Dividend Payments (2018) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Preferred Dividend Payments for 1 consecutive years, with $35712.0 the latest figure, recorded in Q4 2018.
- In Q4 2018, Preferred Dividend Payments changed N/A year-over-year to $35712.0; the TTM figure through Dec 2019 stood at $60292.0 (changed N/A YoY), while the FY2018 annual figure was $123727.0, changed N/A from the prior year.
- Preferred Dividend Payments rose to $35712.0 in Q4 2018 per DCOY's latest filing, from $24580.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $35712.0 in Q4 2018 and bottomed at $24580.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 35,712.00 |
| Sep 30, 2018 | 24,580.00 |